OBJECTIVES: We sought to determine cardiovascular risk factor prevalence rates among adults in Abu Dhabi, United Arab Emirates. METHODS: We used self-reported indicators, anthropometric measures, and blood tests to screen 50 ,138 adults aged 18 years or older taking part in a population-wide cardiovascular screening program. RESULTS: Participants' mean age was 36.82 years (SD = 14.3); 43% were men. Risk factor prevalence rates were as follows: obesity, 35%; overweight, 32%; central obesity, 55%; diabetes, 18%; prediabetes, 27%; dyslipidemia, 44%; and hypertension, 23.1%. In addition, 26% of men were smokers, compared with 0.8% of women. Age-standardized diabetes and prediabetes rates were 25% and 30%, respectively, and age-standardized rates of obesity and overweight were 41% and 34%. CONCLUSIONS: This population-wide cardiovascular screening program demonstrated a high cardiovascular burden for our small sample in Abu Dhabi. The data form a baseline against which interventions can be implemented and progress monitored as part of the population-wide Abu Dhabi Cardiovascular Disease Program.
OBJECTIVES: We sought to determine cardiovascular risk factor prevalence rates among adults in Abu Dhabi, United Arab Emirates. METHODS: We used self-reported indicators, anthropometric measures, and blood tests to screen 50 ,138 adults aged 18 years or older taking part in a population-wide cardiovascular screening program. RESULTS:Participants' mean age was 36.82 years (SD = 14.3); 43% were men. Risk factor prevalence rates were as follows: obesity, 35%; overweight, 32%; central obesity, 55%; diabetes, 18%; prediabetes, 27%; dyslipidemia, 44%; and hypertension, 23.1%. In addition, 26% of men were smokers, compared with 0.8% of women. Age-standardized diabetes and prediabetes rates were 25% and 30%, respectively, and age-standardized rates of obesity and overweight were 41% and 34%. CONCLUSIONS: This population-wide cardiovascular screening program demonstrated a high cardiovascular burden for our small sample in Abu Dhabi. The data form a baseline against which interventions can be implemented and progress monitored as part of the population-wide Abu Dhabi Cardiovascular Disease Program.
Authors: M M Gabir; R L Hanson; D Dabelea; G Imperatore; J Roumain; P H Bennett; W C Knowler Journal: Diabetes Care Date: 2000-08 Impact factor: 19.112
Authors: J E Shaw; P Z Zimmet; M de Courten; G K Dowse; P Chitson; H Gareeboo; F Hemraj; D Fareed; J Tuomilehto; K G Alberti Journal: Diabetes Care Date: 1999-03 Impact factor: 19.112
Authors: David C Ziemer; Paul Kolm; William S Weintraub; Viola Vaccarino; Mary K Rhee; Jennifer G Twombly; K M Venkat Narayan; David D Koch; Lawrence S Phillips Journal: Ann Intern Med Date: 2010-06-15 Impact factor: 25.391
Authors: Majid Ezzati; Stephen Vander Hoorn; Carlene M M Lawes; Rachel Leach; W Philip T James; Alan D Lopez; Anthony Rodgers; Christopher J L Murray Journal: PLoS Med Date: 2005-05-03 Impact factor: 11.069
Authors: Syed M Shah; Tom Loney; Salma Al Dhaheri; Hassan Vatanparast; Iffat Elbarazi; Mukesh Agarwal; Iain Blair; Raghib Ali Journal: BMC Public Health Date: 2015-02-28 Impact factor: 3.295
Authors: Maysm N Mohamad; Leila Cheikh Ismail; Lily Stojanovska; Vasso Apostolopoulos; Jack Feehan; Amjad H Jarrar; Ayesha S Al Dhaheri Journal: PLoS One Date: 2021-06-17 Impact factor: 3.240
Authors: Ahmed Mohammad Makki; Saleh Mohammad Aldaqal; Shahad Hamadan Alorabi; Ismail Ahmed Nemri; Maha Mohammad Alajami Journal: Electron Physician Date: 2016-01-15